IXALTIS engages in developing proprietary therapeutics to treat genitourinary disorders with unsatisfied medical need.Ixaltis' headquarters is located in Archamps, Rhône Alpes, FR 74160. It has raised 8.9M in 1 round. The latest round was in May 2016....
Ixaltis's CEO, Roberto Gradnik, currently has an approval
rating of 70%. Ixaltis's primary competitors are ixaltis.com